Leukocare adds Wolfram Altenhofen to team
This article was originally published in Clinica
Executive Summary
Leukocare has made Wolfram Altenhofen its new vice-president of business development. Dr Altenhofen was previously responsible for building up the firm’s sales forces in Europe and India. This appointment comes as part of the company’s dynamic growth programme, whereby Leukocare also merged their R&D division in Frankfurt with its head office in Munich and relocated to Martinsried on 1 June. Leukocare’s technology involves coupling functional molecules to the surface of medical devices, and stabilising these molecules so that they are not destroyed during sterilisation and other procedures. It has a broad range of applications in the fields of medical devices and diagnostics.
You may also be interested in...
Alere aided by professional diagnostics sales in fourth quarter
Alere’s professional diagnostics business helped the firm record overall revenue growth in the fourth quarter of 2010, offsetting a fall in influenza-based sales in North America.
Integra and Stout to work on expandable interbody device
Integra LifeSciences has gained exclusive worldwide rights from Stout Medical to develop and commercialise an expandable interbody fusion device.
Gen-Probe eyes portfolio expansion to help boost molecular diagnostics credentials
Gen-Probe recently launched its Panther automated molecular diagnostics system in Europe with the aim of bringing another dimension to its product portfolio. Joseph Harvey met the firm’s CEO, Carl Hull, at the launch of the product in Frankfurt to find how high the firm has set its sights in the molecular diagnostics sector and how it is going to achieve its goals